Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: January 9, 2023
Reporting Period: Preliminary unaudited results for the fourth quarter and full year ended December 31, 2022.
The filing serves to announce preliminary revenue estimates and provide a business update. The financial data is subject to the completion of the audit process and may differ materially from final results.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release (Exhibit 99.1) containing preliminary unaudited net revenue estimates for Q4 and full-year 2022, as well as management's projection for 2023 net revenue, but the specific figures are not included in the provided text.
Material Changes
No specific material changes versus prior periods are quantified in the text. The filing notes that actual results could differ materially from the preliminary estimates provided.
Guidance, Outlook, and Risks
- Guidance: Management provided a projection for 2023 net revenue, though the specific target is not stated in this text.
- Outlook: The company issued a business update alongside the preliminary results.
- Risks and Contingencies: The filing includes standard forward-looking statement disclaimers. It cautions investors not to place undue reliance on projections due to risks, uncertainties, and factors beyond the company's control. Investors are directed to the "Risk Factors" section of the Annual Report on Form 10-K filed on March 3, 2022, for detailed risk discussions.
- Unusual Items: None explicitly detailed in the text.
Investor Verification Checklist
- Verify the specific preliminary net revenue figures for Q4 and full-year 2022 in the referenced press release (Exhibit 99.1).
- Confirm the exact 2023 net revenue projection provided by management.
- Review the final audited financial statements once the audit process is complete to compare against these preliminary estimates.
- Consult the Form 10-K filed on March 3, 2022, for a comprehensive list of risk factors.